医学会议分类导航
 
 
领域国际医学会议网公众号
 
首页  
2022年第30届国际血栓与止血大会(ISTH)
     
 

◆ 会议时间:2022年7月9-13日
◆ 会议地点:英国 伦敦(London, England, UK)

 

◆ 会议简介:

2022年第30届国际血栓与止血学会(ISTH)年会将于2022年7月9-13日在英国伦敦举行。ISTH大会是血栓与止血领域最具影响力的国际盛会,数千名世界一流的血栓、止血和血管生物学专家将齐聚一堂,一起展示最新的研究成果,交流最新的科学发现,并论旨在改善患者护理的最新临床应用,促进对血栓和出血性疾病的全面认识、预防、诊断和治疗。ISTH大会原每两年举办一次,从2020年开始改为每年举办一次ISTH年会。

国际血栓与止血学会(ISTH)是一个全球性的非营利性会员组织,成立于1954年,起初命名为国际血栓与止血委员会,1969年正式更为现名。ISTH的使命是宣促进对血栓和出血性疾病的认识、预防、诊断和治疗,包括血小板功能及其调节,血栓形成、纤溶和溶栓机制,以及血栓栓塞性疾病等新兴领域。ISTH发展至今,已成为全球领先的血栓与止血相关的专业组织,在全球98个国家和地区拥有超过5000名成员。——未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。

ISTH 2022 - The XXX Congress of the International Society on Thrombosis and Haemostasis
Date: July 9-13, 2022
Location: London, England, UK

 

摘要征集

Important Dates

  • February 1, 2022 at 17:00 EST (U.S.): Regular Abstract Submission Website Closes (This Will Not Be Extended) 常规摘要投稿截止日期
  • April 20, 2022: Abstract Withdrawal Deadline
  • May 18, 2022: Abstract Titles Released (only confirmed participating abstract titles will be released)
  • May 18, 2022: Late-Breaking Abstract Submission Website Launches
  • June 1, 2022 at 17:00 EST (U.S.): Late-breaking Abstract Submission Website Closes
  • June 24, 2022 at 09:00 EST (U.S.): Full text abstracts are released (excludes Late-breaking)

点此提交摘要>>>Submit Abstract>>>


View Guidelines Below:

Main Topics

  • Acquired Bleeding Disorders
  • Arterial Thromboembolism
  • Coagulation & Natural Anticoagulants
  • COVID and Coagulation
  • Diagnostics and OMICs
  • Fibrinolysis and Proteolysis
  • Hemophilia and Rare Bleeding Disorders
  • Hemostatic Systems in Cancer, Inflammation and Immunity
  • Pediatrics
  • Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies
  • Platelets and Megakaryocytes 
  • Vascular Biology
  • Venous Thromboembolism
  • Women’s Health

​​The content of the abstract must be related to one of the topics listed below. To ensure smooth scoring of papers, the topic of your work must be selected during the submission process.

Acquired Bleeding Disorders

  • Coagulopathy of Major Bleeding (Trauma, PPH, Vascular/surgical, ECMO, GI bleeding, etc.)
  • Management/Treatments of Acquired Bleeding
  • Novel Therapies in the Management of Acquired Bleeding

Arterial Thromboembolism

  • Acute Coronary Syndromes
  • Atherosclerosis
  • Atrial Fibrillation
  • Cardiovascular Risk Factors
  • Cerebrovascular Disorders
  • Peripheral Artery Disease

Coagulation and Natural Anticoagulants

  • Animal Models in Thrombosis and Hemostasis
  • Coagulation Factors and Inhibitors
  • Contact Pathway
  • Critical Care and Perioperative
  • FVIII/IX
  • Hemostasis and Organ Dysfunction
  • Microparticles
  • Protein C Pathway
  • Regulation of Coagulation
  • Tissue Factor Pathway

COVID and Coagulation

  • COVID and Coagulation, Basic Science
  • COVID and Coagulation, Clinical

Diagnostics and OMICs

  • Biomarkers of Thrombosis and Hemostasis
  • Blood Components and Management
  • Cellular Therapies
  • Epigenetics, OMICs and Bioinformatics
  • Laboratory Diagnostics
  • Nanotechnology and Novel Biomolecules

Fibrinolysis and Proteolysis

  • Fibrinogen and Factor XIII
  • Fibrinolytic Factors and Inhibitors
  • Plasminogen Activation in the CNS and Immunity
  • Thrombolytic Therapy

Hemophilia and Rare Bleeding Disorders

  • Acquired Hemorrhagic Coagulation Disorders
  • Disseminated Intravascular Coagulation
  • Hemophilia - Basic
  • Hemophilia - Clinical
  • Hemophilia - Gene Therapy
  • Management of Bleeding and Trauma
  • Novel Biotherapeutics in Hemophilia
  • Rare Bleeding Disorders

Hemostatic System in Cancer, Inflammation and Immunity

  • Coagulation Proteins Beyond Hemostasis
  • Complement and Hemostatic System
  • Infection and Hemostatic Factors
  • Platelets and Cancer
  • Platelets and Infection
  • Platelets and Inflammation
  • Proteases and Cancer

Nurses and Allied Health

  • Nurses and Allied Health

Pediatrics

  • Bleeding in Neonates and Children
  • Thrombosis in Neonates and Children

Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies

  • Acquired Thrombocytopenias
  • ADAMTS13 and TTP
  • Antiplatelet Therapy
  • HIT
  • HUS
  • Inherited Thrombocytopenias
  • Non HUS/TTP Microangiopathies
  • Platelet Antagonists and Novel Therapeutics
  • Platelet Function Disorders, Acquired
  • Platelet Function Disorders, Hereditary
  • von Willebrand Factor Biology
  • VWF and von Willebrand Factor Disorders - Clinical Conditions

Platelets and Megakaryocytes

  • Megakaryocytes and Thrombopoiesis
  • Platelet Function and Interactions
  • Platelet Proteomics and Genomics
  • Platelet Receptors
  • Platelet Signaling

Vascular Biology

  • Blood Cells and Vessel Wall
  • Endothelial Cell Signaling
  • Inflammation and Sepsis
  • Innate and Adaptive Immunity
  • Non-coding RNAs
  • Protease Activated Receptors
  • Stem Cells and Vascular Cell Growth

Venous Thromboembolism

  • Antiphospholipid Syndrome
  • Artificial Valves
  • Cancer Associated Thrombosis
  • Genetic Risk Factors of Thrombosis
  • Post-thrombotic Syndrome
  • Thrombophilia
  • Visceral Vein Thrombosis
  • VTE Diagnosis
  • VTE Epidemiology
  • VTE Prophylaxis
  • VTE Treatment

Women's Health

  • Estrogens and Progestinics
  • Pregnancy and Pregnancy Complications

How to Submit an Abstract

  • Delegates, who would like to present their work at the congress, either orally or as a poster, are invited to submit an abstract for consideration by the Scientific Committee.
  • ISTH Members and Non-Members are invited to submit abstracts.
  • There are no fees to submit an abstract.
  • Abstracts can only be submitted online via the abstract submission website that can be found in the section “Abstract Guidelines” on the official ISTH 2022 Congress website. Abstracts sent by post or email will not be accepted. No exceptions will be made.
  • The submitter will be required to login with your ISTH Member login credentials or create a user account in order to submit an abstract. Once logged in you will be able to submit your abstract.
  • Abstracts can be saved in "Draft” status and be re-edited and modified until the submission deadline (February 1, 2022, 17:00 Eastern Standard Time (U.S.).
    • ou can still make edits to abstracts that have been submitted, but you will need to re-submit it before the deadline to be considered.
  • The submitted/draft abstracts cannot be edited after the submission deadline.
  • Only abstracts that have been submitted properly will be considered for the congress.
  • Any technical questions regarding the submission website should be sent to abstracts@isth.org.

General Guidelines

  • The abstract must address scientific questions, detail clinical observations, or contain primary scientific data.
  • Abstracts should be submitted in clear English to allow the reviewers to focus on the scientific content of the abstract. Non-English speaking authors are encouraged to have their abstract checked for grammar and spelling.
  • Please ensure your abstract does not contain spelling, grammar, or scientific mistakes, as it will be reproduced exactly as submitted. Linguistic accuracy is your responsibility. No proof reading will be done.
  • Do not slice results from the same study into multiple abstracts. The Scientific Committee reserves the right to reject abstracts when inappropriate slicing of data is suspected. Similarly, do not submit a copy or close copy of an abstract under more than one (1) topic. Abstracts that appear to be submitted multiple times under different topics will be rejected.
  • All research and studies in submitted abstracts that involve human subjects or experimental animals must comply with the Declaration of Helsinki.
  • No revisions can be made after the abstract deadline. To ensure the integrity of the review process, revisions to abstracts will not be accepted after the abstract submission deadline.

 

ISTH 2022 注册费-Registration Rates:

Registration Types:

  • In-Person Registration:  Includes full access to all activities on site, including lunch and coffee. In-person registration also includes access to the virtual components during the meeting, plus 60 days after. 
  • Virtual Registration Live +14: Includes full access to the virtual components of the Congress, both live and for 14 days following the Congress. Full program details for the virtual components will be provided soon. 
  • Virtual Registration Live +60: Includes full access to the virtual components of the Congress, both live and for 60 days following the Congress.

Timelines & Deadlines:​

  • Early Registration Deadline: April 7, 2022
  • On-Site Registrations Begin: July 5, 2022
  • Cancellation Deadline: June 9, 2022


 

* This Category is available for three years following completion of clinical training (medical residency, and/or fellowship), or once an independent faculty or tenured position is obtained.

** This category is open to Nurses, AHP's and Technicians.
*** This category is open to any person  not holding a doctoral degree currently and involved in a training program for medical education or other disciplines or in a M.Sc. or Ph.D. program
**** This category is open to any person holding a doctoral degree who is engaged in any one or a combination of the following: a period of clinical training, formal post-doctoral mentored research, scholarly or practical training for the purpose of acquiring specific professional skills and/or a medical fellow.
***** This category is open to any clinician, researcher or educator from one of the countries classified as a low, lower-middle or upper-middle income economy by World Bank Classification.

 

◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。

 
 
※相关服务※
会议注册服务:30美金起/人/次(服务费)+ 会议注册费(按官方规定收取,注册类别请咨询客服);
出境签证服务:1500元人民币/人/次(美国,含签证费),其它国家咨询客服;
大会投稿服务:30美金/人/次,官方收取费用另计(如有);
会员申请服务:30-100美金/人/次;

团组参会、行程定制,以及需要其它服务(如接送机等),请直接联系客服。


 
咨询报名:
李老师
400-089-1003(微信扫描右侧二维码咨询)
 
 
领域国际医学会议网——专注专业的国际医学会议服务商,专业服务医学相关群体!
 
  领域国际医学会议网介绍/联系  
版权所有:领域国际医学会议网 未经许可禁止复制转载摘录镜像本站任何内容! 隐私政策/版权/免责声明 | 联系我们